Attached files

file filename
EX-32.1 - EX-32.1 - T2 Biosystems, Inc.ttoo-ex321_7.htm
EX-31.2 - EX-31.2 - T2 Biosystems, Inc.ttoo-ex312_6.htm
EX-31.1 - EX-31.1 - T2 Biosystems, Inc.ttoo-ex311_9.htm
EX-21.1 - EX-21.1 - T2 Biosystems, Inc.ttoo-ex211_10.htm
EX-10.46 - EX-10.46 - T2 Biosystems, Inc.ttoo-ex1046_517.htm
EX-10.45 - EX-10.45 - T2 Biosystems, Inc.ttoo-ex1045_516.htm
EX-10.44 - EX-10.44 - T2 Biosystems, Inc.ttoo-ex1044_518.htm
EX-10.43 - EX-10.43 - T2 Biosystems, Inc.ttoo-ex1043_507.htm
EX-10.42 - EX-10.42 - T2 Biosystems, Inc.ttoo-ex1042_510.htm
EX-10.41 - EX-10.41 - T2 Biosystems, Inc.ttoo-ex1041_513.htm
EX-10.40 - EX-10.40 - T2 Biosystems, Inc.ttoo-ex1040_512.htm
EX-10.39 - EX-10.39 - T2 Biosystems, Inc.ttoo-ex1039_514.htm
EX-10.38 - EX-10.38 - T2 Biosystems, Inc.ttoo-ex1038_511.htm
EX-10.37 - EX-10.37 - T2 Biosystems, Inc.ttoo-ex1037_508.htm
EX-10.36 - EX-10.36 - T2 Biosystems, Inc.ttoo-ex1036_515.htm
EX-10.35 - EX-10.35 - T2 Biosystems, Inc.ttoo-ex1035_509.htm
EX-10.22 - EX-10.22 - T2 Biosystems, Inc.ttoo-ex1022_17.htm
EX-10.21 - EX-10.21 - T2 Biosystems, Inc.ttoo-ex1021_16.htm
EX-10.2 - EX-10.2 - T2 Biosystems, Inc.ttoo-ex102_788.htm
10-K - 10-K - T2 Biosystems, Inc.ttoo-10k_20171231.htm

 

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following Registration Statements:           

 

 

(1) 

Registration Statement (Form S-3 No. 333-206707) of T2 Biosystems, Inc.,

 

(2)

Registration Statement (Form S-3 No. 333-216833) of T2 Biosystems, Inc., and

 

(3)

 

 

Registration Statement (Form S-8 No. 333-197946) pertaining to the Amended and Restated 2006 Employee, Director and Consultant Stock Plan, 2014 Incentive Award Plan, and the 2014 Employee Stock Purchase Plan of T2 Biosystems, Inc.

 

 

 

of our report dated March 19, 2018, with respect to the consolidated financial statements of T2 Biosystems, Inc. included in this Annual Report (Form 10-K) of T2 Biosystems, Inc. for the year ended December 31, 2017.

 

 

 

 

/s/ Ernst & Young LLP

 

Boston, Massachusetts

March 19, 2018